TRAF2 and B-cell non-Hodgkin lymphoma: Our studies provide insight into mechanisms regulating DNA damage-induced apoptosis in B cells and may help develop effective therapies for TRAF2/3 mutant B-cell lymphomas using IAP antagonist.